MedPath

Gonadotropin-releasing hormone (GnRH) antagonist vs. gonadotropin-releasing hormone agonist protocol for in vitro fertilization in non-obese patients with Polycystic Ovary Syndrome (PCOS). A prospective randomized study.

Phase 3
Completed
Conditions
GnRH antagonists in PCOS
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
Registration Number
ACTRN12607000636459
Lead Sponsor
State Committee for Scientific Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
70
Inclusion Criteria

1. meeting of 2003 Rotterdam PCOS criteria; 2. age=40 years; 3. body mass index <27 kg/m2; 4. FSH < 12 mIU/ml on the 3rd day of the cycle; 5. negative screening for hepatitis B and C virus infection and human immunodeficiency virus (HIV) infection.

Exclusion Criteria

>2 miscarriages, >3 unsuccessful IVF/ICSI cycles, anatomical abnormalities of the uterus on laparoscopy or hysteroscopy and existence of ovarian cysts.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath